trending Market Intelligence /marketintelligence/en/news-insights/trending/0u1ax_vf-0lrhr48no8ska2 content esgSubNav
In This List

Bio-Rad receives NYSE noncompliance notice for failing to file annual report

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Blog

Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook


Bio-Rad receives NYSE noncompliance notice for failing to file annual report

Bio-Rad Laboratories Inc. said it received a noncompliance notice from the New York Stock Exchange for failing to file its annual report on time.

The Hercules, Calif.-based life sciences company said the delay was caused by its accounting firm, which is still auditing its results for the fiscal year ended Dec. 31, 2017.

The company has six months from the date the filing was originally due to submit its annual report. Once it files the report, it will regain compliance with the stock exchange's listing requirements.